Fluticasone Propionate Multidose Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Inhaler

Study Title

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Teva Identifier

FSS-AS-30003 | 2016-003835-39

ClinicalTrials.gov Identifier

NCT02980133

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Fluticasone Propionate | Drug: Fluticasone Propionate/Salmeterol | Drug: Placebo MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

December 28, 2016 - April 13, 2019

Phase

Phase 3

Additional info


Study Type

Interventional